Hyster-Yale vs Toro
HY and TTC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HY and TTC compare
Toro is the larger company, worth 20 times as much as Hyster-Yale ($10.2B against $511M).
Toro grew revenue faster over the last twelve months (5.2% versus −11.1% for Hyster-Yale).
Toro keeps more of each dollar of sales as profit, with a net margin of 7.6% compared with −3.3% at Hyster-Yale.
Both pay dividends: Hyster-Yale yields 5.1% and Toro 1.4%.
Toro scores higher on the StockData Score (16 against 8 for Hyster-Yale), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HY | TTC |
|---|---|---|
| Size and price | ||
| Market cap | $511M | $10.2B |
| Share price | $28.49 | $107.96 |
| Change, 1 year | −21.8% | 43.6% |
| Change, 5 years | −35.5% | 9.2% |
| Beta (5Y) | 1.15 | 0.97 |
| Employees | 7,500 | – |
| StockData Score | ||
| Total score | 8 | 16 (better) |
| Valuation score | 3 (better) | 1 |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | – | 28.9× |
| P/S | 0.1× (better) | 2.2× |
| P/B | 1.3× (better) | 7.6× |
| EV/EBITDA | – | 17.3× |
| P/FCF | 34.5× | 14.4× (better) |
| FCF yield | 2.9% | 7.0% (better) |
| Fair value | $63.54 | $93.72 |
| Margin of safety | 55.2% (better) | −15.2% |
| Growth | ||
| Revenue growth (TTM) | −11.1% | 5.2% (better) |
| Revenue growth, 5Y average | 6.0% (better) | 5.9% |
| Net income growth (TTM) | −627% | 9.1% (better) |
| EPS growth (TTM) | −629% | 13.3% (better) |
| EPS growth, 5Y average | – | 0.91% |
| Profitability | ||
| Gross margin | 15.4% | 33.4% (better) |
| Operating margin | −2.3% | 10.3% (better) |
| Net margin | −3.3% | 7.6% (better) |
| FCF margin | 0.42% | 15.0% (better) |
| Return on equity | −25.0% | 26.4% (better) |
| Return on invested capital | −8.1% | 17.6% (better) |
| Financial health | ||
| Debt / equity | 1.03 | 0.72 (better) |
| Net debt / EBITDA | – | 1.24 |
| Interest coverage | −2.7× | 8.7× (better) |
| Current ratio | 1.28 | 1.58 (better) |
| Altman Z-score | 2.21 | 5.33 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 5.1% (better) | 1.4% |
| Payout ratio | – | 41.3% |
| Years of dividend growth | 12 | 16 (better) |
| Dividend growth, 5Y average | 2.4% | 8.7% (better) |
| Buyback yield | −1.6% | 3.5% (better) |
| Shareholder yield | 3.5% | 4.9% (better) |
| Ownership | ||
| Held by institutions | 48.6% | 94.3% |
| Held by insiders | 48.3% | 0.39% |
| Insider net buying, 12 months | – | −$14.2M |
| Short interest, % of float | 7.2% | 4.3% |
Go deeper
- HY stock overview
- HY income statement
- HY valuation and score
- TTC stock overview
- TTC income statement
- TTC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.